Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Toru Kiguchi"'
Autor:
Sayaka Kiso, Hiroyuki Sugiura, Taiga Kuroi, Rika Omote, Tomohiro Toji, Tatsunori Ishikawa, Sachiyo Okamoto, Naho Nomura, Taro Masunari, Nobuo Sezaki, Toru Kiguchi, Mitsune Tanimoto
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1725-1732 (2021)
The concurrent onset of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) is rare, and no autopsy case has been reported. We report herein the first case of concurrent-onset CLL and AML with an atypical phenotype revealed by autopsy
Externí odkaz:
https://doaj.org/article/911c674abc774f718300cb43ef1a1383
Autor:
Hiroyuki Sugiura, Nobuo Sezaki, Tatsunori Ishikawa, Taiga Kuroi, Sachiyo Okamoto, Naho Nomura, Taro Masunari, Yukio Nakasako, Toru Kiguchi, Mitsune Tanimoto
Publikováno v:
Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a se
Externí odkaz:
https://doaj.org/article/f7a27f2a8f31442eb5be844f117f201b
Autor:
Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 66-75 (2020)
Abstract: The prognostic impact of KIT mutation on core-binding factor acute myeloid leukemia (CBF-AML) remains controversial. We registered 199 newly diagnosed de novo CBF-AML patients, aged 16 to 64 years, who achieved complete remission. They rece
Externí odkaz:
https://doaj.org/article/d8f98219f90f425d95e4fd4f64876f2b
Autor:
Toru Kiguchi, Yasushi Hiramatsu, Shuichi Ota, Michihiro Uchiyama, Moe Matsuo, Miyu Okamura, Shimpei Morimoto, Yoshinori Tanizawa, Masaomi Tajimi, Payakachat, Nalin
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2024, Vol. 64 Issue 2, p119-128, 10p
Autor:
Takayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, Naoko Hosono, Yasuyoshi Morita, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, Keisuke Matsubara, Saori Sugimoto, Yasushi Miyazaki, Masahiro Kizaki, Koichi Akashi
Publikováno v:
Cancer Science. 113:4258-4266
Therapeutic improvements are needed for patients with acute myeloid leukemia (AML), particularly those who have relapsed or who have treatment-refractory (R/R) AML or newly diagnosed patients with poor prognostic factors. Alvocidib (DSP-2033), a pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60e8cc6a916c28c54f4d279a39f0a86
https://doi.org/10.1111/cas.15458
https://doi.org/10.1111/cas.15458
Autor:
Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda, Maria Creignou, Lanying Zhao, Manabu Kusakabe, Yuhei Shibata, Nobuhiko Nakamura, Mizuki Watanabe, Nobuhiro Hiramoto, Yusuke Shiozawa, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Yoshida, Nobuyuki Kakiuchi, Hideki Makishima, Masahiro Marshall Nakagawa, Kensuke Usuki, Mitsumasa Watanabe, Kazunori Imada, Hiroshi Handa, Masataka Taguchi, Toru Kiguchi, Kazuma Ohyashiki, Takayuki Ishikawa, Akifumi Takaori-Kondo, Hisashi Tsurumi, Senji Kasahara, Shigeru Chiba, Tomoki Naoe, Satoru Miyano, Elli Papaemmanuil, Yasushi Miyazaki, Eva Hellström Lindberg, Seishi Ogawa
Publikováno v:
Blood Advances.
Azacitidine is a mainstay of therapy for MDS-related diseases. The purpose of our study is to elucidate the effect of gene mutations on hematological response and overall survival (OS), particularly focusing on their post-treatment clone size. We enr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f90bbc4fc5144aac390a67a2b01bd9c1
https://doi.org/10.1182/bloodadvances.2022009564
https://doi.org/10.1182/bloodadvances.2022009564
Autor:
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia C. Korotev, Carmelo Gurnari, June Takeda, Yukihide Momozawa, Steve Best, Pramila Krishnamurthy, Tetsuichi Yoshizato, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Yasunobu Nagata, Nobuyuki Kakiuchi, Makoto Onizuka, Kenichi Chiba, Hiroko Tanaka, Ayana Kon, Yotaro Ochi, Masahiro Marshall Nakagawa, Rurika Okuda, Takuto Mori, Akinori Yoda, Hidehiro Itonaga, Yasushi Miyazaki, Masashi Sanada, Takayuki Ishikawa, Shigeru Chiba, Hisashi Tsurumi, Senji Kasahara, Carsten Müller-Tidow, Akifumi Takaori-Kondo, Kazuma Ohyashiki, Toru Kiguchi, Fumihiko Matsuda, Joop H. Jansen, Chantana Polprasert, Piers Blombery, Yoichiro Kamatani, Satoru Miyano, Luca Malcovati, Torsten Haferlach, Michiaki Kubo, Mario Cazzola, Austin Kulasekararaj, Lucy A. Godley, Jaroslaw P. Maciejewski, Seishi Ogawa
Publikováno v:
Blood. 140:208-210
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc40055598943540f15d078e88c504e
https://doi.org/10.1182/blood-2022-158851
https://doi.org/10.1182/blood-2022-158851
Autor:
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia Korotev, Carmelo Gurnari, June Takeda, Yukihide Momozawa, Steve Best, Pramila Krishnamurthy, Tetsuichi Yoshizato, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Yasunobu Nagata, Nobuyuki Kakiuchi, Makoto Onizuka, Kenichi Chiba, Hiroko Tanaka, Ayana Kon, Yotaro Ochi, Masahiro M. Nakagawa, Rurika Okuda, Takuto Mori, Akinori Yoda, Hidehiro Itonaga, Yasushi Miyazaki, Masashi Sanada, Takayuki Ishikawa, Shigeru Chiba, Hisashi Tsurumi, Senji Kasahara, Carsten Müller-Tidow, Akifumi Takaori-Kondo, Kazuma Ohyashiki, Toru Kiguchi, Fumihiko Matsuda, Joop H. Jansen, Chantana Polprasert, Piers Blombery, Yoichiro Kamatani, Satoru Miyano, Luca Malcovati, Torsten Haferlach, Michiaki Kubo, Mario Cazzola, Austin G. Kulasekararaj, Lucy A. Godley, Jaroslaw P. Maciejewski, Seishi Ogawa
Publikováno v:
Blood, 141, 5, pp. 534-549
Blood, 141, 534-549
Blood, 141, 534-549
Germ line DDX41 variants have been implicated in late-onset myeloid neoplasms (MNs). Despite an increasing number of publications, many important features of DDX41-mutated MNs remain to be elucidated. Here we performed a comprehensive characterizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac9c3319f0625df782abbb83676c1407
https://repository.ubn.ru.nl/handle/2066/290823
https://repository.ubn.ru.nl/handle/2066/290823
Autor:
Tomohiro Toji, Taro Masunari, Rika Omote, Sayaka Kiso, Toru Kiguchi, Tatsunori Ishikawa, Taiga Kuroi, Mitsune Tanimoto, Sachiyo Okamoto, Hiroyuki Sugiura, Nobuo Sezaki, Naho Nomura
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1725-1732 (2021)
Case Reports in Oncology
Case Reports in Oncology
The concurrent onset of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) is rare, and no autopsy case has been reported. We report herein the first case of concurrent-onset CLL and AML with an atypical phenotype revealed by autopsy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c63fd0f0a1ed0b8ea1f0aa2b009f0f91
https://www.karger.com/Article/FullText/520427
https://www.karger.com/Article/FullText/520427
Autor:
Kazutaka Sunami, Shin‐ichi Fuchida, Kenshi Suzuki, Masaki Ri, Morio Matsumoto, Chihiro Shimazaki, Hideki Asaoku, Hirohiko Shibayama, Kenichi Ishizawa, Hiroyuki Takamatsu, Takashi Ikeda, Dai Maruyama, Kazunori Imada, Michihiro Uchiyama, Toru Kiguchi, Satoshi Iyama, Hirokazu Murakami, Reiko Onishi, Keisuke Tada, Shinsuke Iida
Publikováno v:
Hematological oncologyREFERENCES.
The primary analysis of the phase 1/2 ISLANDs study in Japanese individuals with relapsed/refractory multiple myeloma (RRMM) showed that isatuximab monotherapy was well tolerated and effective, even in participants with high-risk cytogenetic abnormal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7e61ae3682a73047a4b7ac6fef1737
https://pubmed.ncbi.nlm.nih.gov/36433829
https://pubmed.ncbi.nlm.nih.gov/36433829